Max Robotics — Global Service Robot Directory + US Certification

About

Rafael Ribeiro Zanotti is a surgical oncologist whose research centers on the surgical management of renal cell carcinoma (RCC), particularly in complex cases involving tumor thrombus. His major contributions lie in comparing the safety and efficacy of open, laparoscopic, and robotic approaches for radical nephrectomy with tumor thrombectomy (RN-TT) and cytoreductive nephrectomy with tumor thrombectomy (CN-TT) in metastatic RCC. Through the Intercontinental Collaboration on Renal Cell Carcinoma, Zanotti has led landmark studies that systematically evaluate perioperative outcomes and overall survival across these surgical modalities. His 2025 publications, each garnering 2 citations, provide critical evidence for surgical decision-making in this high-risk patient population. By analyzing large, multi-institutional datasets, Zanotti’s work helps clarify the trade-offs between minimally invasive techniques and traditional open surgery, offering guidance on optimizing oncologic control while minimizing morbidity. His research is particularly valuable for urologic oncologists and surgeons seeking to refine their approach to RCC with tumor thrombus, a technically demanding condition. Zanotti’s collaborative, evidence-based methodology positions him as a rising authority in the comparative effectiveness of surgical techniques for advanced kidney cancer.